HPC
ZOM

HM Payson & Co’s Zomedica Corp. ZOM Stock Holding History

HM Payson & Co’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-250
Closed -$30 – 1093
2024
Q4 		$30 Hold
250
– – ﹤0.01% 1031
2024
Q3 		$35 Hold
250
– – ﹤0.01% 1113
2024
Q2 		$37 Hold
250
– – ﹤0.01% 990
2024
Q1 		$37 Hold
250
– – ﹤0.01% 957
2023
Q4 		$51 Hold
250
– – ﹤0.01% 957
2023
Q3 		$42 Hold
250
– – ﹤0.01% 995
2023
Q2 		$50 Hold
250
– – ﹤0.01% 989
2023
Q1 		$53 Hold
250
– – ﹤0.01% 1012
2022
Q4 		$41 Hold
250
– – ﹤0.01% 926
2022
Q3 		$0 Hold
250
– – ﹤0.01% 1117
2022
Q2 		$0 Hold
250
– – ﹤0.01% 1193
2022
Q1 		$0 Hold
250
– – ﹤0.01% 1192
2021
Q4 		$0 Hold
250
– – ﹤0.01% 1205
2021
Q3 		$0 Hold
250
– – ﹤0.01% 1155
2021
Q2 		$0 Hold
250
– – ﹤0.01% 1216
2021
Q1 		$0 Buy
+250
New +$409 ﹤0.01% 1216

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

HM Payson & Co's ZOM Position: Q1 2025 in Review

HM Payson & Co sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 250 shares — an estimated $30 sold.

HM Payson & Co first reported a position in ZOM in Q1 2021 and held it in 16 quarters. The position peaked at $53 in Q1 2023. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • HM Payson & Co reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • HM Payson & Co sold 250 Zomedica Corp. shares in Q1 2025, an estimated $30.
  • HM Payson & Co first reported a position in Zomedica Corp. in Q1 2021 and held it in 16 quarters.
  • HM Payson & Co's Zomedica Corp. position peaked at $53 in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on HM Payson & Co's 13F filing for Q1 2025, filed 29 Apr 2025.